Dr. Hana Lotan is an international oncology expert, specializing in breast cancer. Dr. Lotan is a senior physician in the Department of Oncology at Assuta, Israel’s largest medical center. Holds the position of Medical Director of Eli Lilly Pharmaceutical Company, head of the medical and regulatory group, involved in drug development. Clinical experience of more than 31 years. The doctor is fluent in English and Hebrew.
EDUCATION
- NV – Senior Physician, Department of Oncology, Assuta Medical Center, Ramat ha-Hayal, Assuta
- 2011 – NV – Consultant on research and development, business development for pharmaceutical and biotechnology companies
- 2012 – 2013 – Senior physician, Department of Oncology, Breast Cancer Unit, M.D. Anderson Cancer Center. Chaim Sheba, Tel ha-Schomer, Israel
- 1998 – 2011 – Medical Director, Director of New Product Planning at Eli Lilly Medical Center, Israel
- 1998 – 2011 – Global External Research and Development (GERD organization) at Eli Lilly, Israel
- 2005 – 2006 – Medical Director, Eli Lilly, South Africa
- 1998 – 2011 – Senior Physician, Department of Oncology, Hadassah Medical Center, Jerusalem, Israel
- 1990 – 1998 – Physician, Department of Oncology, Hadassah Medical Center, Jerusalem, Israel
- 1981 – 1983 – Fogarty International Center Fellow, Laboratory of Molecular Pharmacology, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA
- 1978 – 1980 – Research Associate, Biophysics, Michigan State University, USA
KNOWLEDGE OF LANGUAGES
Hebrew
English
MEMBERSHIP IN INTERNATIONAL ASSOCIATIONS
- 1987 – Doctor of Medicine (MD) degree from Tel Aviv University, Israel
- 1978 – Ph.D. degree in organic chemistry from the Hebrew University, Jerusalem, Israel
- 1973 – PhD degree in organic chemistry from the City University of New York (CUNY), USA
- 1969 – Bachelor’s and Master’s degrees in chemistry and physics, from the Hebrew University, Jerusalem, Israel